Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease

Published:2023-03 Issue: Volume:355 Page:42-53
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Chikamatsu Mayuko,Watanabe Hiroshi,Shintani Yuhi,Murata Ryota,Miyahisa Masako,Nishinoiri Ayano,Imafuku Tadashi,Takano Mei,Arimura Nanaka,Yamada Kohichi,Kamimura Miya,Mukai Baki,Satoh Takao,Maeda Hitoshi,Maruyama Toru

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference65 articles.

1. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;Younossi;Hepatology,2019

2. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease;Estes;Hepatology,2018

3. Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States;Kim;Hepatology,2019

4. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

5. Nonalcoholic steatohepatitis;Reid;Gastroenterology,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation;Biochemical and Biophysical Research Communications;2024-11

2. Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation;Redox Biology;2024-10

3. High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis;Journal of Autoimmunity;2024-09

4. Therapeutic evaluation of the novel FGF21 analogue DC2303 for metabolic dysfunction-associated steatohepatitis;2024-08-26

5. Double promoter and tandem gene strategy for efficiently expressing recombinant FGF21;Microbial Cell Factories;2024-06-12